Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)
Loading
Please wait while we load your information from QuoteMedia.